150 related articles for article (PubMed ID: 15613927)
1. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
[No Abstract] [Full Text] [Related]
2. Severe intra-abdominal bleeding post liver biopsy - failure to respond to recombinant Factor VII.
Quinn JP; Murphy PT
Thromb Haemost; 2004 Mar; 91(3):632-3. PubMed ID: 14983243
[No Abstract] [Full Text] [Related]
3. Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy.
Hoffman R; Mahajana A; Agmon P; Baruch Y; Brenner B
Thromb Haemost; 2002 Feb; 87(2):346-7. PubMed ID: 11858500
[No Abstract] [Full Text] [Related]
4. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
Martínez J; Cid AR; de la Rubia J; Gimeno R
Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
[TBL] [Abstract][Full Text] [Related]
5. Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa.
Agarwal N; Spahr JE; Rodgers GM
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):205-7. PubMed ID: 17287641
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
[TBL] [Abstract][Full Text] [Related]
7. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
[TBL] [Abstract][Full Text] [Related]
8. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
Cervera JS; Mena-Durán AV; Piqueras CS
Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
[No Abstract] [Full Text] [Related]
11. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B
J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480
[No Abstract] [Full Text] [Related]
12. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver S; Andoljsek D; Cernelc P
Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
[No Abstract] [Full Text] [Related]
13. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
Tonkic A; Jukic I; Titlic M; Mise S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725
[No Abstract] [Full Text] [Related]
14. Use of Novoseven for arsenic trioxide-induced bleeding in PML.
Alimoghaddam K; Ghavamzadeh A; Jahani M
Am J Hematol; 2006 Sep; 81(9):720. PubMed ID: 16804937
[No Abstract] [Full Text] [Related]
15. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
[No Abstract] [Full Text] [Related]
16. NovoSeven for non-hemophilia hemostasis.
Med Lett Drugs Ther; 2004 Apr; 46(1181):33-4. PubMed ID: 15114252
[No Abstract] [Full Text] [Related]
17. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
Branch DW; Rodgers GM
Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
[No Abstract] [Full Text] [Related]
18. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.
Karimi M; Zakerinia M; Khojasteh HN; Ramzi M; Ahmad E
J Thromb Haemost; 2004 Oct; 2(10):1853-5. PubMed ID: 15456505
[No Abstract] [Full Text] [Related]
19. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
20. More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation.
Marietta M; Facchini L; Girardis M; Luppi M; Torelli G
J Thromb Haemost; 2006 Jan; 4(1):288. PubMed ID: 16409495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
